4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-011437
SVP & Chief Commercial Officer sold 4,852 shares at $10.95 ($53,129)
From the SEC's structured data for this filing
Trades in this filing
NORTHCOTT JOHN · SVP & Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-16 | Sale : show line 1 in the form | −4,852 | $10.95 | $53,129 | 227,802 | D |
| Open-market sales · 4,852 sh · avg $10.95 · $53,129 | ||||||
Loading xslF345X03/doc4.xml…